The consistent theory proposed in these studies was the potential positive impact of Ipamorelin on bone mineral density
The incretin hormone glucagon-like peptide 1 (GLP-1) is secreted by enteroendocrine cells of the intestinal epithelium, and there is evidence that it is neuroprotective in animal models and human subjects with PD
Do not take in larger amounts than advised/prescribed
These include: Gallstones and gallbladder issues, thought to be caused by rapid weight loss Pancreatitis studies have shown a higher risk for this condition while taking GLP-1 medications compared to other weight loss medications Gastroparesis (delayed stomach emptying) though these medications are designed to slow down digestion, if it slows down too much, it can lead to other symptoms and complications Kidney damage, typically resulting from dehydration caused by other side effects A potential risk of thyroid cancer animal studies have shown an increased risk for thyroid C-cell tumors, though that risk has not yet been confirmed in humans GLP-1 medications can be a powerful tool for people to improve their health, but theyre not for everyone
They will evaluate your medical history, check for B12 deficiency via lab work if needed, discuss your goals (energy, wellness, overall health), and then recommend a tailored injection plan including cost, schedule and any recommended follow-up.
/assets/images/provider/photos/2764906.jpg)
